Home › Calculator › SNY Dividend Calculator 2026
SNY DRIP Calculator & Dividend Yield 2026
5.77% YieldHealthcareSanofi · NASDAQ
Price: $41.89 · Annual div: $2.42/share · Frequency: annual · Payout ratio: 76% · Ex-div: 2026-05-04
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SNY pays your bills
Year your monthly dividend income covers each expense (based on current settings)
SNY Dividend History — Last 26 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-05-04Latest | 2026-06-03 | $2.4190 | 10.01% | $46.08 |
| 2025-05-09 | 2025-06-12 | $2.1953 | 4.06% | $54.10 |
| 2024-05-09 | 2024-06-06 | $2.0369 | 7.88% | $50.03 |
| 2023-05-30 | 2023-06-23 | $1.9030 | 3.56% | $53.44 |
| 2022-05-26 | 2022-06-27 | $0.2970 | 3.85% | $53.06 |
| 2022-05-04 | 2022-05-31 | $1.7470 | 3.29% | $53.06 |
| 2021-05-03 | 2021-05-26 | $1.9060 | 3.75% | $50.89 |
| 2020-04-30 | 2020-05-26 | $1.7530 | — | — |
| 2019-05-07 | 2019-05-31 | $1.7390 | — | — |
| 2018-05-09 | 2018-06-04 | $1.8610 | — | — |
| 2017-05-11 | 2017-06-07 | $1.5770 | — | — |
| 2016-05-05 | 2016-06-01 | $1.6300 | — | — |
| 2015-05-06 | 2015-06-02 | $1.6180 | — | — |
| 2014-05-07 | 2014-06-05 | $1.9100 | — | — |
| 2013-05-06 | 2013-06-05 | $1.8620 | — | — |
| 2012-05-07 | 2012-05-30 | $1.7560 | — | — |
| 2011-05-11 | 2011-06-24 | $1.8220 | — | — |
| 2010-05-17 | — | $1.6270 | — | — |
| 2009-04-20 | — | $1.4190 | — | — |
| 2008-05-16 | — | $1.5100 | — | — |
| 2007-06-04 | — | $1.1450 | — | — |
| 2006-06-02 | — | $0.9120 | — | — |
| 2005-06-02 | — | $0.7990 | — | — |
| 2004-09-27 | — | $0.0300 | — | — |
| 2004-04-30 | — | $0.5800 | — | — |
| 2003-05-28 | — | $0.4620 | — | — |
About Sanofi (SNY) — Dividend Analysis 2026
Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The company strategically organizes its operations into three core divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare. Within its Pharmaceutical segment, Sanofi delivers specialized therapies, including innovative human monoclonal antibodies, addressing complex conditions like multiple sclerosis, various neurological disorders, immunology and inflammatory diseases, oncology, rare diseases, and rare blood disorders. This segment also encompasses treatments for diabetes, cardiovascular health, and established prescription medications. Its Vaccine portfolio is extensive, offering essential immunizations such as pediatric vaccines for poliomyelitis, pertussis, and Hib, alongside influenza shots, adult boosters, meningitis vaccines, and solutions for travel and endemic diseases. The Consumer Healthcare division provides a broad spectrum of over-the-counter products, including remedies for allergies, coughs and colds, pain management, liver support, physical and mental wellness, probiotics, digestive health aids, and nutritional supplements. Additionally, it offers various personal care items like daily body lotions, anti-itch creams, moisturizing and soothing lotions, body and foot creams, and specialized powders for eczema. Sanofi maintains a robust development pipeline, with numerous pharmaceutical products and vaccines currently in various stages of research. The company actively pursues strategic alliances, exemplified by its collaboration with GlaxoSmithKline on a recombinant Covid-19 vaccine, a research partnership with Stanford University School of Medicine focused on advancing immunology and inflammation understanding, and a collaboration and license option agreement with Prellis Biologics, Inc. Founded in 1973 and headquartered in Paris, France, the company was formerly known as Sanofi-Aventis before officially changing its name to Sanofi in May 2011.
Similar dividend stocks to SNY
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SNY DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SNY position with:
🌍 SNY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SNY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 5.77% | 2.97% | $577 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 4.90% | 2.10% | $490 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 4.62% | 1.82% | $462 / yr |
| 🇬🇧 UK ISA | 0% | 5.77% | 2.97% | $577 / yr |
| 🇬🇧 UK Taxable | 8.75% | 5.27% | 2.47% | $527 / yr |
| 🇨🇦 TFSA | 0% | 5.77% | 2.97% | $577 / yr |
| 🇨🇦 CA Taxable | 25% | 4.33% | 1.53% | $433 / yr |
| 🇦🇺 Super (pension) | 15% | 4.90% | 2.10% | $490 / yr |
| 🇦🇺 AU Taxable | 30% | 4.04% | 1.24% | $404 / yr |
| 🇩🇪 DE Taxable | 26.375% | 4.25% | 1.45% | $425 / yr |
| 🇫🇷 FR Taxable | 30% | 4.04% | 1.24% | $404 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SNY Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.42/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SNY Dividend Payment Schedule
SNY pays annually — 1 payment per year.
📊 SNY vs Healthcare Benchmarks
How SNY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SNY sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SNY Insider Activity
No recent SEC filings reported in the last 90 days.Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare SNY with peers: SNY vs AMGN · SNY vs BMY · SNY vs CVS
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where SNY earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SNY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Sanofi (SNY) is currently trading at $41.89, 20% below its 52-week high. The current dividend yield is 5.77% based on an annual payout of $2.42 per share.
SNY (Sanofi) — 5.77% Dividend Yield Analysis
Sanofi (SNY) is a healthcare stock currently trading at $41.89 with a dividend yield of 5.77%. It pays an annual dividend of $2.42 per share. The payout ratio of 76% indicates investors should monitor dividend sustainability. Over the past 5 years, SNY has grown its dividend at a compound annual rate of 7.0%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest SNY News
LiveHow investors use the SNY dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.